Apple
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Apple sits in the top decile of US sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count).
Apple: 12 sponsored US clinical trials, 2 recruiting.
Apple sponsors 12 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 7 completed. The most-studied condition in this pipeline is Atrial Fibrillation, with 2 trials.
Top-decile sponsor footprint
Apple ranks in the top decile of sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
12 total, page 1 of 1
Apple Health Study
NCT06958523
Apple Women's Health Study
NCT04196595
Apple Hearing Study
NCT04172766
Apple Heart & Movement Study
NCT04198194
Smartphone Enabled Hearing Study
NCT05872035
Cycle and Ovulation Study Expansion
NCT05852951
Apple Respiratory Study
NCT04912180
Atrial Fibrillation Algorithms Clinical Validation Study
NCT04699812
ECG App Algorithms Clinical Validation Study
NCT04247581
Evaluation of the Use of Apple Watch Features for Identification of Cardiac Arrhythmias
NCT03769207
Electrocardiogram Clinical Validation Study
NCT03492554
Apple Heart Study: Assessment of Wristwatch-Based Photoplethysmography to Identify Cardiac Arrhythmias
NCT03335800
Therapeutic Areas
What is open in the Apple pipeline
2 recruiting of 12 indexed (17% open); 7 completed (58%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Atrial Fibrillation (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Apple: open-pipeline peers nationwide
Peers matched on 12 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Apple sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 12 trials (± recruiting share)
- Alachua Government Services · 12 trials · 0% recruiting
- Allergy Therapeutics · 12 trials · 0% recruiting
- Ampio Pharmaceuticals. · 12 trials · 0% recruiting
- Angiodynamics · 12 trials · 17% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Adagene · 17% recruiting · 6 trials
- Agendia · 17% recruiting · 6 trials
- Akamis Bio · 17% recruiting · 6 trials
- Anthos Therapeutics · 17% recruiting · 6 trials
Related
What to do with this Apple page
12 registered trials is a research-attention snapshot, not an endorsement of Apple or any single study.
- 2 of Apple's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Atrial Fibrillation is the condition Apple studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Atrial Fibrillation trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Apple pipeline card: 12 registered trials from official public datasets.Report a data error.